financetom
XOS
financetom
/
Industrials
/
XOS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Xos, Inc.XOS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
27.39M
Revenue (ttm)
55.96M
Net Income (ttm)
-50.16M
Shares Out
8.10M
EPS (ttm)
-6.69
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
9,957
Open
3.350
Previous Close
3.390
Day's Range
3.232 - 3.380
52-Week Range
2.730 - 9.220
Beta
1.80
Analysts
Buy
Price Target
10.00 (+195.86%)
Earnings Date
May 14, 2025
Description >

Xos, Inc. designs, manufactures, and sells battery-electric commercial vehicles.

It also offers a range of services to facilitate the transition of fleets to electric vehicles, including charging infrastructure, vehicle maintenance, financing, and service.

The company was founded in 2020 and is headquartered in Los Angeles, California.

Latest News >
Guardant Health Shares Halted; FDA Panel to Review Premarket Application of Colorectal Cancer Screening Test
Guardant Health Shares Halted; FDA Panel to Review Premarket Application of Colorectal Cancer Screening Test
May 23, 2024
07:57 AM EDT, 05/23/2024 (MT Newswires) -- Guardant Health ( GH ) shares were temporarily halted on Thursday as a Food and Drug Administration panel prepared to meet to review the premarket approval application for the company's Shield blood test to screen for colorectal cancer. Advisory committees provide independent expert advice and non-binding recommendations to the FDA, the company said....
Tango Therapeutics Discontinues TNG348 Program After Showing Liver Toxicity in Trials; Shares Tumble Premarket
Tango Therapeutics Discontinues TNG348 Program After Showing Liver Toxicity in Trials; Shares Tumble Premarket
May 23, 2024
07:55 AM EDT, 05/23/2024 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Thursday it will discontinue developing its TNG348 program due to liver toxicity experienced by patients during clinical trials. Patients remaining in the study for more than eight weeks exhibited liver function abnormalities, leading to the decision to terminate the program, Tango said. TNG348 was being developed as...
Update: Market Chatter: Google Chooses State in Southern India for Smartphone Production
Update: Market Chatter: Google Chooses State in Southern India for Smartphone Production
May 23, 2024
07:57 AM EDT, 05/23/2024 (MT Newswires) -- (Updates with additional details.) Alphabet's (GOOG) Google ( GOOG ) is planning to invest billions of dollars in India's southern state of Tamil Nadu to set up production of its Pixel phones, Bloomberg reported Thursday, citing unnamed people familiar with the matter. Tamil Nadu's Minister for Industries T.R.B. Rajaa and other senior officials...
Market Chatter: Goldman Sachs Gets First-Ever Saudi HQ License for Wall Street Bank
Market Chatter: Goldman Sachs Gets First-Ever Saudi HQ License for Wall Street Bank
May 23, 2024
07:56 AM EDT, 05/23/2024 (MT Newswires) -- Goldman Sachs Group ( GS ) became the first Wall Street bank to receive a license from Saudi Arabia to set up its regional headquarters in Riyadh, Bloomberg reported Thursday, citing people familiar with the matter. Under state contract rules issued in 2021 that went into effect this year, firms must have a...
Copyright 2023-2025 - www.financetom.com All Rights Reserved